← SynDRA
ALMITRINE
SynDRA canonical compound SYN0022832 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | ATP1A1 |
| Mechanism of action | Neurotransmitter agonist |
| Indication | chronic obstructive pulmonary disease (COPD) |
| Disease area | pulmonary |
All known targets
Mechanisms of action (all sources)
- Neurotransmitter agonist
- ATP1A1 BINDER
Drug classes
- Central Nervous System Agents
- Neuroprotective Agents
- Protective Agents
- Respiratory System Agents
ATC classes
- R07A · OTHER RESPIRATORY SYSTEM PRODUCTS
Cross-references
Synonyms
- almitrine mesylate
- almitrine mesilate
- duxil
- almitrine dimesilate
- almitrine dimesylate
- Almitrina
- Almitrin
- Almitrinum
- Vectarion
- Almitrine bismesylate
- Almitrine dimesylate
- S 2620
- Almitrina [INN-Spanish]
- Almitrine (INN)
- Almitrine Bis(methanesulfonate)
- Almitrine [BAN:INN]
- Almitrine [INN:BAN]
- Almitrinum [INN-Latin]
- N,N'-diallyl-6-{4-[bis(4-fluorophenyl)methyl]piperazin-1-yl}-1,3,5-triazine-2,4-diamine
- 2,4-Bis(allylamino)-6-(4-(bis(p-fluorophenyl)methyl)-1-piperazinyl)-s-triazine
- 2,4-bis[allylamino]-6-[4-[bis(p-fluorophenyl)methyl]-1-piperazinyl]-s-triazine
- 6-(4-(Bis(4-fluorphenyl)methyl)-1-piperazinyl)-N,N'-di-2-propenyl-1,3,5-triazin-2,4-diamin
- 6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-N,4-N-bis(prop-2-enyl)-1,3,5-triazine-2,4-diamine
- SE-5023
- 9A1222NBG4
- CHEBI:53778
- Monomesylate, Almitrine
- RefChem:110940
- DTXCID5031682
- R07AB07
- ALMITRINE [INN]
- EINECS 248-475-5
- S-2620
- UNII-9A1222NBG4
- ALMITRINE [MI]
- ALMITRINE [WHO-DD]
- SCHEMBL769301
- OBDOVFRMEYHSQB-UHFFFAOYSA-N
Look up ALMITRINE in the interactive SynDRA portal →